Skip to Content
 

News: Translational Research and Interventional Oncology Research Program

Grant to help address complexity of cancer care

Wednesday, January 16th, 2019

Lung cancer survival signal

Saturday, December 1st, 2018

A recent study shows that a cell receptor, SSTR2, is a candidate biomarker for poor prognosis and a potential therapeutic target for small cell lung cancer.

Teamwork key to treating patient’s rare blood cancer

Saturday, December 1st, 2018

Patient Joe Lofaro credits the teamwork of Nishitha Reddy, MBBS, MSCI, and other clinicians at VUMC for diagnosing him with the rare blood cancer Erdheim-Chester disease.

Immunotherapies linked to specific heart complications

Tuesday, November 20th, 2018

Cardiovascular complications linked to immune checkpoint inhibitors include myocarditis, pericarditis, vasculitis and arrhythmias and occur early in the course of treatment, Vanderbilt researchers report.

Warner’s medical informatics research recognized

Monday, November 5th, 2018

Jeremy Warner, MD, is the 2018 recipient of the New Investigator Award from the American Medical Informatics Association (AMIA).

Combination therapy improves small-cell lung cancer survival

Friday, October 26th, 2018

Patients who received atezolizumab in addition to standard chemotherapy lived two months longer than those treated with chemotherapy alone, according to a recent study published in the New England Journal of Medicine.

Study tracks incidence, timing of immunotherapy-related deaths

Thursday, September 13th, 2018

Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

Using light to fight GVHD

Tuesday, September 4th, 2018

Vanderbilt investigators have conducted a prospective multicenter study on how extracorporeal photopheresis works in treating chronic graft-versus-host disease (cGVHD) — a complication of bone marrow or stem cell transplant that occurs when donor cells attack the recipient.

A new target for lung cancer

Tuesday, August 21st, 2018

A recent study suggests that a transporter protein called xCT may be potential therapeutic target in lung cancer.

Grant bolsters kidney cancer immunotherapy research

Friday, May 11th, 2018

Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

Next Page »